SYNLAB International GmbH has acquired Yhtyneet Medix Laboratoriot Oy

Target Company Name:
Country:
Advisory:
Sector:
Partner:

Yhtyneet Medix Laboratoriot Oy
Finland
Advisor to the seller
Healthcare & Pharmaceuticals
Aventum Partners

SYNLAB acquires 100 % of the shares in Yhtyneet Medix Laboratoriot Oy. Aventum acted as advisor to Aho Group and Minerva Foundation and other selling shareholders of YML.

Acquisition of leading Finnish laboratory services provider

Advisor to the seller :
Aventum Partners

Experts who worked on this transaction

Riikka Makinen

Director at Aventum Partners

Joona Kalliokoski

Director at Aventum Partners

Relevant transactions

Transactions

United States Drug Testing Laboratories Inc. acquired by Northlane Capital Partners.

Advisor to the seller :
Brown Gibbons Lang & Company

Project Amygdala

Private Equity

Sale of mental health services provider for high-acuity individuals in the UK

Advisor to the seller :
Cooper Parry Corporate Finance

Private Investors

Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors

Advisor to the seller :
RIóN

icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM

Advisor